More specifically, the relative decrease in LFC was 29.8%, 47.1%, and 39.6%, with tirzepatide at 5, 10, and 15 mg/week, respectively, compared to 11.2% with insulin degludec (2)
Microdosing helps reduce the cost of these medications as this practice extends the time of Mounjaro and Zepbound usage
There are numerous studies in the general population and among patients with chronic kidney disease that show glucagon-like peptide-1 (GLP-1) medications are safe and effective for weight loss. Formed in March 2024, the Comprehensive Transplant Centers kidney transplant weight loss program uses a combination of diet, exercise, counseling and weight loss injection medication to help patients reach weight loss goals to make them eligible for transplantation
Immortal time bias in observational studies
A phase I/II, two-part, multicenter, first-in-human study of DS-7300a in patients with advanced solid malignant tumors
(PubMed) Shinto L, Quinn J, Montine T, et al